Defects of intrinsic and innate immunity

Gene: TRAF3IP2

Green List (high evidence)

TRAF3IP2 (TRAF3 interacting protein 2)
EnsemblGeneIds (GRCh38): ENSG00000056972
EnsemblGeneIds (GRCh37): ENSG00000056972
OMIM: 607043, ClinGen, DECIPHER
TRAF3IP2 is in 3 panels

2 reviews

Krithika Murali (Victorian Clinical Genetics Services)

Green List (high evidence)

Multiple additional families reported with AR ACT1 deficiency and biallelic TRAF31P2 variants predicted to result in LoF. Chronic mucocutaneous candidiasis is a key phenotypic feature. Functional assays demonstrate loss of protein expression and impaired IL‑17 signaling.
Created: 2 Mar 2026, 10:06 p.m. | Last Modified: 2 Mar 2026, 10:06 p.m.
Panel Version: 1.4467

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
candidiasis, familial, 8, MONDO:0014230; ?Candidiasis, familial, 8 - MIM#615527

Publications

Zornitza Stark (Victorian Clinical Genetics Services)

I don't know

Two unrelated individuals reported, plausible biological candidate as TRAF3IP2 is an adaptor protein involved in downstream signalling for IL-17 receptors.
Created: 12 Apr 2020, 2:16 p.m. | Last Modified: 12 Apr 2020, 2:16 p.m.
Panel Version: 0.37

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Candidiasis, familial, 8, MIM# 615527

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Melbourne Genomics Health Alliance Immunology Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Candidiasis, familial, 8, MIM# 615527
OMIM
607043
ClinGen
TRAF3IP2
DECIPHER
TRAF3IP2
Clinvar variants
Variants in TRAF3IP2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

2 Mar 2026, Gel status: 3

Set publications

Krithika Murali (Victorian Clinical Genetics Services)

Publications for gene: TRAF3IP2 were set to 34289170; 33825088; 33359359; 32350852; 31292894; 30237576; 28640246

2 Mar 2026, Gel status: 3

Entity classified by Genomics England curator

Krithika Murali (Victorian Clinical Genetics Services)

Gene: traf3ip2 has been classified as Green List (High Evidence).

2 Mar 2026, Gel status: 3

Set publications

Krithika Murali (Victorian Clinical Genetics Services)

Publications for gene: TRAF3IP2 were set to 24120361; 31292894; 20660351

2 Mar 2026, Gel status: 3

Entity classified by Genomics England curator

Krithika Murali (Victorian Clinical Genetics Services)

Gene: traf3ip2 has been classified as Green List (High Evidence).

12 Apr 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: traf3ip2 has been classified as Amber List (Moderate Evidence).

12 Apr 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: TRAF3IP2 were changed from to Candidiasis, familial, 8, MIM# 615527

12 Apr 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: TRAF3IP2 were set to

12 Apr 2020, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: TRAF3IP2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

12 Apr 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: traf3ip2 has been classified as Amber List (Moderate Evidence).

18 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: TRAF3IP2 was added gene: TRAF3IP2 was added to Defects of innate immunity_MGHA_AGHA_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TRAF3IP2 was set to Unknown